Selection committee

Adrian Radu is an accomplished engineering leader with nearly 20 years of experience in automotive and satellite communications, specializing in embedded systems, wireless technologies, and AI-driven solutions. He has collaborated with the European and Romanian Space Agencies to deliver innovative satellite communication systems and led global teams in developing advanced vehicle access technologies. As co-founder of the One Health Incubator, Adrian is dedicated to fostering biotech innovation and entrepreneurship in Romania. With a passion for integrating AI into life sciences, he combines his technical expertise and leadership experience to support the growth of a thriving biotech ecosystem.

“My mission is to help grow biotech by strengthening the local ecosystem, building practical AI and tech solutions, and supporting health-tech startups. I aim to make a real impact in healthcare by enabling new companies and researchers to tackle today’s biotech challenges.”

Alexandru Botos has an extensive background in biotechnology products, services, and business development. His expertise encompasses biotech service management, scientific staff coaching, and customer training, honed over the years in both startup and multinational company environments. Alexandru’s work focuses on optimising biotech operations, with a proven ability to grow biotech businesses and lead teams through complex development processes. His dedication to advancing biotechnology extends to fostering an innovative environment where service and product development are seamlessly integrated. By leveraging his experience across diverse biotechnology sectors, Alexandru contributes to advancing impactful biotech solutions. He remains committed to helping organisations navigate the challenges of biotechnology service delivery and develop strategies that align with scientific advancements and market needs.

“My mission is to empower world-class research and innovation in Romania.”

Timmy is a creative technologist, startup founder, and ecosystem builder with a decade of experience at the forefront of immersive innovation, AI, and urban tech. He is the co-founder of MidBrain, an AI venture focused on emotionally intelligent agents, and founder of The Point Labs, a studio known as the “New Immersive Bauhaus,” working at the intersection of technology, culture, and design.

During his 10+ years at Volvo Cars, Timmy led global innovation strategy – bridging mobility, healthcare, and smart cities through open innovation and startup partnerships. He built and scaled programs across San Francisco, Tel Aviv, and Europe, working closely with founders, investing in early-stage startups, and integrating cutting-edge solutions into industry workflows.

In addition to founding companies, Timmy is an active angel investor and VC advisor, collaborating with funds and accelerator networks such as SXSW, AWE, and Cannes. He supports founders from idea to scale, helping shape Europe’s next generation of deep tech and creative companies. His work merges strategic foresight, real-world prototyping, and community design—fuelling systems-level innovation across industries.

Daniela Pavlicenco is a scientist driven by a passion for genetics, immunology, and nanomedicine, with a strong focus on translating research into clinical applications. Her current research centres on identifying cellular and molecular traits within endometrial cancer cell subpopulations that drive metastasis, targeting innovative treatments for cancer. Daniela’s commitment to bridging groundbreaking research and healthcare has led her toward biotech entrepreneurship, where she seeks to translate scientific discoveries into real-world health solutions. With a forward-looking approach, she actively engages in the scientific community, seeking collaboration and continuous learning. Daniela is motivated by a desire to positively impact patient outcomes and is eager to contribute to the advancement of personalised medicine.

“My personal mission is to help reduce the gap between fundamental scientific discoveries and their eventual application in the healthcare system. I aspire to help create an incubator that empowers startups to scale their innovative solutions, ultimately transforming lives for the better. This mission aligns with my values and interests.”

​Oxentia Ltd is an innovation management and technology commercialisation consultancy that started in 2004 as an operating division within Oxford University Innovation Ltd, the world leading technology transfer company of the University of Oxford. Oxentia’s mission is to provide high quality innovation management consulting services and advice, derived directly from practitioners’ perspectives to organisations around the world, adding value and enabling economic growth at all levels. Since inception, Oxentia has engaged with large corporate businesses and SMEs, university spinouts, research organisations foundations, and governments as well as academics from research institutions and universities across most continents of the world.

We have managed a diverse range of cultural approaches within different socio-economic environments, which has given us a unique perspective on innovation and commercialisation strategies that can be implemented in different regions and countries. Our team has an exceptional blend of technical and commercial experience that cuts across most research disciplines, which makes us uniquely suited to engage with international tech-based innovators. To date, Oxentia has worked with clients in more than 70 countries supporting over 10,000 innovators.

Ion is director of innovation and co-founder at FreshBlood HealthTech (part of Asociatia INIT), adjunct professor at the Department of Public Health of the Babes Bolyai University of Cluj-Napoca, ecosystem development director of the HIVE – Health Innovation Center, and has been Starship Biodesign Fellow of EITHealth since 2017.

Ion is a medical doctor, marketer, community leader and business shaping consultant.

Having graduated Human Medicine at the University of Medicine and Pharmacy in Cluj-Napoca, Transylvania, Romania, Ion has been active for 25+ years in the healthcare field, with growing responsibilities and impact in several multinational companies and then in entrepreneurial projects.

Since 2016, Ion has focused on improving healthcare through innovation, supporting startups and innovative healthtech projects as co-founder of FreshBlood HealthTech.  He is a business development consultant for tech-powered projects in healthcare, angel investor and startup advisor.

At Oxentia, Andreea manages and delivers strategic innovation and technology commercialisation projects for UK Universities, government sector clients and R&I funders, such as Wellcome and the Foreign, Commonwealth and Development Office (FCDO). She has experience in the early-stage Biotech, CleanTech and Digital technology space gained through several licensing and market strategy projects, as well as through her work as a start-up mentor for Scottish Enterprise and Santander. Andreea managed the Research England-funded Shared Technology Transfer Office in Advanced Engineering and Manufacturing for the Midlands (STTOAEMM), a consortium of six partners, led by the University of Warwick. STTOAEMM aimed to support universities with smaller or less resourced technology transfer offices by sharing expertise, networks, and resources to build a stronger commercialisation pipeline. 

Andreea is keen to apply her expertise working in multidisciplinary teams together with technical experts, commercial teams and business mentors. She also manages the innovation function at Oxentia (new product development) which involves promoting and implementing new offerings and products to grow the business: prioritising, tracking and managing a small portfolio of internal projects, in close collaboration with the Senior Leadership Team. 

Andreea is qualified as an Agile project manager and holds a MSc in Pharmacology from the University of Oxford. Before joining Oxentia in 2021, Andreea was a Development Scientist at Oxford Nanopore Technologies, where she worked on developing a sequencing-based COVID-19 diagnostic kit.

Fabio joined Oxentia in 2019, bringing  experience in biomedical engineering and life science and commercial and business development experience in an Oxford University spin-out manufacturing medical devices and in-vitro diagnostics.

At Oxentia, Fabio leads work in Entrepreneurship programmes, designing and managing accelerators, internationalisation programmes, and capacity building for entrepreneurs around the world.

Selected project experience includes the Newton-funded Royal Academy of Engineering Leaders in Innovation Fellowships, the Santander X Entrepreneurship Educator’s programme, the Santander X Global Challenges, the Santander X Global Awards, and the JETRO X-HUB London programme. Within these projects, Fabio has managed and coordinated large teams and budgets, managing client and relationships between multiple stakeholders.  Fabio also has experience working in Academic settings, by supporting Open University projects ranging from astrophysics to Children’s literacy, and supporting the development of Oxford University’s accelerator offering. Furthermore, Fabio has supported technology scouting and licensing projects for corporate and academic clients, and is also a mentor and expert for EIT Health. Fabio is also an advisor for the Serbian Government through the World Bank’s SAIGE programme.

Fabio is fluent in English and Italian and has a working knowledge of French. He holds an MEng in Mechatronics (King’s College London), an MSc in Biomedical Engineering (Oxford) and a DPhil (PhD) in Engineering Science (Oxford).

Michael-Bogdan Marginanu is a biomedical scientist with 13 years of experience in research institutions worldwide, including Germany, Saudi Arabia, the UK, Ireland, Austria, the US, Switzerland, and Romania. A 2018 Lindau Nobel Laureate Meetings alumnus, he co-founded the Lindau Mentoring Hub and established Biomentorhub, a nonprofit organisation dedicated to mentoring young scientists and promoting bioentrepreneurship in Romania. His scientific work is complemented by a deep commitment to fostering innovation and supporting the next generation of researchers and entrepreneurs. Michael-Bogdan’s efforts in developing bio-entrepreneurship in Romania are aimed at creating opportunities for young scientists, bridging international knowledge with local potential, and building a vibrant, supportive community for life sciences advancement.

“My mission as a co-founder, team lead and facilitator is helping each team member bring the most valuable contribution to creating a first community-driven happy culture bioscience innovation hub in Romania.”